Regulated expression of erythropoietin from an AAV vector safely improves the anemia of β-thalassemia in a mouse model
Open Access
- 30 April 2003
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 7 (4) , 493-497
- https://doi.org/10.1016/s1525-0016(03)00043-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- βMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in β thalassemic mice after erythropoietin complementary DNA electrotransfer in musclesBlood, 2001
- Improvement of erythropoiesis in β-thalassemic mice by continuous erythropoietin delivery from muscleBlood, 2000
- Quantitative PCR analysis of HbF inducers in primary human adult erythroid cellsBlood, 2000
- Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblastsGene Therapy, 1999
- Administration of high doses of recombinant human erythropoietin to patients with β‐thalassemia intermedia: a preliminary trialEuropean Journal of Haematology, 1997
- Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta- thalassemiaBlood, 1994
- Trial of recombinant human erythropoietin: three patients with thalassemia intermedia [letter]Blood, 1992
- Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial [letter]Blood, 1991
- The pharmacology of hemoglobin switching: of mice and menBlood, 1991
- Stimulation of Fetal Hemoglobin Synthesis by Erythropoietin in BaboonsNew England Journal of Medicine, 1987